Vascular endothelial growth factor in chronic rat allograft nephropathy

Neufeld, 1999, Vascular endothelial growth factor (VEGF) and its receptors, FASEB J, 13, 9, 10.1096/fasebj.13.1.9

Zachary, 2000, Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor, Arterioscler Thromb Vasc Biol, 20, 1512, 10.1161/01.ATV.20.6.1512

Barleon, 1996, Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1, Blood, 87, 3336, 10.1182/blood.V87.8.3336.bloodjournal8783336

Clauss, 1990, Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration, J Exp Med, 172, 1535, 10.1084/jem.172.6.1535

Grosskreutz, 1999, Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro, Microvasc Res, 58, 128, 10.1006/mvre.1999.2171

Wang, 1998, Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1, Circ Res, 83, 832, 10.1161/01.RES.83.8.832

Celletti, 2001, Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque, J Am Coll Cardiol, 37, 2126, 10.1016/S0735-1097(01)01301-8

Brown, 1992, Vascular permeability factor mRNA and protein expression in human kidney, Kidney Int, 42, 1457, 10.1038/ki.1992.441

Simon, 1998, Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites, J Am Soc Nephrol, 9, 1032, 10.1681/ASN.V961032

Noguchi, 1998, Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerulonephritis, J Am Soc Nephrol, 9, 1815, 10.1681/ASN.V9101815

Shulman, 1996, Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases, J Am Soc Nephrol, 7, 661, 10.1681/ASN.V75661

Honkanen, 2003, Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical course, Am J Kidney Dis, 42, 1139, 10.1053/j.ajkd.2003.08.014

Cha, 2000, Role of vascular endothelial growth factor in diabetic nephropathy, Kidney Int Suppl, 77, S104, 10.1046/j.1523-1755.2000.07717.x

Wada, 2002, Impairment of vascular regeneration precedes progressive glomerulosclerosis in anti-Thy 1 glomerulonephritis, Kidney Int, 61, 432, 10.1046/j.1523-1755.2002.00137.x

Kang, 2001, Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1, J Am Soc Nephrol, 12, 1434, 10.1681/ASN.V1271434

Ostendorf, 1999, VEGF(165) mediates glomerular endothelial repair, J Clin Invest, 104, 913, 10.1172/JCI6740

Kang, 2001, Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function, J Am Soc Nephrol, 12, 1448, 10.1681/ASN.V1271448

Lemstrom, 2002, Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis, Circulation, 105, 2524, 10.1161/01.CIR.0000016821.76177.D2

Raisky, 2007, VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts, Arterioscler Thromb Vasc Biol, 27, 819, 10.1161/01.ATV.0000260001.55955.6c

Tambur, 2006, Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy, J Heart Lung Transplant, 25, 690, 10.1016/j.healun.2006.02.006

Pilmore, 1999, Vascular endothelial growth factor expression in human chronic renal allograft rejection, Transplantation, 67, 929, 10.1097/00007890-199903270-00024

Cao, 2006, Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection, Transplant Proc, 38, 1998, 10.1016/j.transproceed.2006.06.081

Lemos, 2005, The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation, Transplantation, 79, 1221, 10.1097/01.TP.0000161219.75906.EC

Wood, 2000, PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration, Cancer Res, 60, 2178

Savikko, 2003, Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy, Transplantation, 75, 1147, 10.1097/01.TP.0000062836.93496.CE

Isoniemi, 1994, Histological chronic allograft damage index accurately predicts chronic renal allograft rejection, Transplantation, 58, 1195, 10.1097/00007890-199412150-00010

Minchenko, 1994, Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo, Lab Invest, 71, 374

Marti, 1998, Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors, Proc Natl Acad Sci U S A, 95, 15809, 10.1073/pnas.95.26.15809

Ben-Av, 1995, Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis, FEBS Lett, 372, 83, 10.1016/0014-5793(95)00956-A

Li, 1995, Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells, J Biol Chem, 270, 308, 10.1074/jbc.270.1.308

Cohen, 1996, Interleukin 6 induces the expression of vascular endothelial growth factor, J Biol Chem, 271, 736, 10.1074/jbc.271.2.736

Ryuto, 1996, Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1, J Biol Chem, 271, 28220, 10.1074/jbc.271.45.28220

Pertovaara, 1994, Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells, J Biol Chem, 269, 6271, 10.1016/S0021-9258(17)37365-9

Finkenzeller, 1997, Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression, Oncogene, 15, 669, 10.1038/sj.onc.1201219

Freeman, 1995, Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis, Cancer Res, 55, 4140

Melter, 2000, Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo, Blood, 96, 3801, 10.1182/blood.V96.12.3801

Hellstrom, 1999, Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse, Development, 126, 3047, 10.1242/dev.126.14.3047

Simper, 2002, Smooth muscle progenitor cells in human blood, Circulation, 106, 1199, 10.1161/01.CIR.0000031525.61826.A8

Yamashita, 2000, Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors, Nature, 408, 92, 10.1038/35040568

Reinders, 2003, Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection, Transplantation, 76, 224, 10.1097/01.TP.0000071363.55007.D0

Ozdemir, 2005, Vascular endothelial growth factor expression and cyclosporine toxicity in renal allograft rejection, Am J Transplant, 5, 766, 10.1111/j.1600-6143.2005.00772.x